MedWatch

AJ Vaccines brings in former Lundbeck exec as new CEO

At the end of January, Jesper Helmuth Larsen left AJ Vaccines, which he had led since 2019. Former Lundbeck and Otsuka exec Ole Vahlgren is now picking up the CEO mantle.

After two years at the helm, Jesper Helmuth Larsen has decided to step down from his CEO position as AJ Vaccines | Photo: Jan Bjarke Mindegaard / Watch Medier

On February 1, a ”change of guards” is taking place at AJ Vaccines, as the company puts it in a press release. Jesper Helmuth Larsen is stepping down as CEO and Ole Vahlgren is taking over the reins.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs